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Abstract.  The 200-kD subunit of neurofilaments 
(NF-H) functions as a cross-bridge between neurofila- 
ments and the neuronal  c2¢toskeleton. In this study, 
four phosphorylated NF-H variants were identified as 
major constituents of axons from a  single neuron type, 
the retinal  ganglion  cell, and were shown to have char- 
acteristics with different functional implications. 
We resolved four major Coomassie Blue-stained 
proteins with apparent molecular masses of 197, 200, 
205, and 210 kD on high resolution one-dimensional 
SDS-polyacrylamide gels of mouse optic axons (optic 
nerve and optic tract).  Proteins with the same elec- 
trophoretic mobilities were radiolabeled within retinal 
ganglion cells in vivo after injecting mice intravitreally 
with [35S]methionine  or [3H]proline.  Extraction of the 
radiolabeled protein fraction with  1% Triton X-100 
distinguished  four insoluble polypeptides (P197,  P200, 
P205,  P210)  with expected characteristics  of NF-H 
from two soluble neuronal  polypeptides (S197,  $200) 
with few properties of neurofilament proteins.  The 
four Triton-insoluble polypeptides displayed greater 
than 90%  structural  homology by two-dimensional 
a-chymotryptic iodopeptide map analysis and cross- 
reacted with four different monoclonal and polyclonal 
antibodies to NF-H by immunoblot analysis.  Each of 
these four polypeptides advanced along axons primar- 
ily in the Group V  (SCa) phase of axoplasmic trans- 
port.  By contrast,  the two Triton-soluble polypeptides 
displayed only a minor degree of a-chymotryptic pep- 
tide homology with the Triton-insoluble NF-H forms, 
did not cross-react with NF-H antibodies, and moved 
primarily  in the Group IV (SCb) wave of axoplasmic 
transport.  The four NF-H variants were generated by 
phosphorylation of a  single polypeptide.  Each of these 
polypeptides incorporated 32p when retinal ganglion 
cells were radiolabeled in vivo with [nP]or- 
thophosphate and each cross-reacted with monoclonal 
antibodies specifically directed against phosphorylated 
epitopes on NF-H. When dephosphorylated in vitro 
with alkaline phosphatase,  the four variants disap- 
peared,  giving rise to a  single polypeptide with the 
same apparent molecular mass (160 kD) as newly syn- 
thesized,  unmodified NF-H. 
The NF-H variants distributed differently along optic 
axons.  P197 predominated at proximal axonal levels; 
P200 displayed a relatively uniform distribution;  and 
P205 and P210 became increasingly prominent at 
more distal axonal levels, paralleling  the distribution 
of the stationary neurofilament network.  Semiquantita- 
tive analyses of pulse-radiolabeled NF-H variants be- 
tween 3 and 60 d after synthesis showed that P197 
was the principal  NF-H variant composing neurofila- 
ments in the axonally transported  wave as this wave 
advanced along axons at the optic nerve level. Long 
after the neurofilament transport wave had reached 
nerve terminals  (60 d after injection),  P210 and P205 
remained prominently radiolabeled along axons,  indi- 
cating that these variants were the major NF-H con- 
stituents of neurofilaments associated with the station- 
ary cytoskeleton. 
On the basis of these data,  we propose that phos- 
phorylation regulates the specific association of 
neurofilaments with different domains of the neuronal 
cytoskeleton. Changes  in the phosphorylation state of 
NF-H during  axoplasmic transport may represent one 
of the mechanisms that triggers the integration of mov- 
ing neurofilaments into the stationary cytoskeleton. 
Portions of this work have appeared in abstract form (1985.  Trans. Am. Soc. 
Neurochem.  16:245a.  [Abstr.];  1987.  Soc.  Neurosci.  Abstr.  13:1513a. 
lAbstr.]). 
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VTOSKELETAL  proteins in many tissues exhibit struc- 
tural microheterogeneity. Isoforms of tubulin (6,  10, 
46, 49, 68), actin (50),  microtubule-associated pro- 
teins (23, 51, 68, 70), and other cytoskeletal proteins (13, 22, 
39, 40,  54,  90),  generated by genetic or posttranslational 
mechanisms, may display selectivity for a particular tissue 
or cell type or may appear at a specific stage of  cellular devel- 
opment. In addition, multiple structural variants of a protein 
are sometimes observed within the same differentiated cell 
(23, 40, 80, 90). Although their presence within single cells 
could reflect the transition of a polypeptide from a precursor 
form to a fully functional state, variants arising by posttran- 
scriptional or posttranslational processing may also amplify 
the range of functions that a single gene product serves in 
different sites within the cell. 
Proteins made up of neurofilaments, the intermediate fila- 
ments of neurons, are extensively modified after synthesis (3, 
30, 31, 59, 63, 64, 80, 81), and the complexity of these post- 
translational processing events  (1,  18,  60,  61,  66,  69,  84) 
holds important clues to the function of these cytoskeletal 
elements. Neurofilaments comprise three subunits (26, 78, 
83, 85), referred to as high, middle, and low molecular mass 
neurofilament proteins (NF-H,  NF-M,  and NF-L,  respec- 
tively), ~ to denote their relative molecular sizes (160-210, 
140-160,  and 70 kD). Microheterogeneity of the neurofila- 
ment triplet proteins is generated by limited proteolysis (58, 
63), phosphorylation (4,  18, 20, 30, 41, 61, 66, 69), and de- 
phosphorylation (60). The NF-H and NF-M subunits, in par- 
ticular, are among the most highly phosphorylated proteins 
in the brain (8, 29, 30), and phosphorylated forms of NF-H 
and NF-M display different  physicochemical properties from 
those of their unmodified counterparts (30, 32).  Since most 
newly synthesized neurofilament proteins are destined for 
posttranslational modification and export into axons, it is un- 
clear whether relatively unmodified neurofilament proteins 
are transient precursors to more mature polypeptides or rep- 
resent functional constituents of the perikaryal cytoskeleton. 
Microdifferentiation of the neurofilament network has been 
suggested by the segregation in some neurons of relatively 
poorly phosphorylated neurofilaments within neuronal peri- 
karya and extensively phosphorylated neurofilaments within 
axons (1, 2,  18,  19, 42, 60, 69, 80). 
Evidence that NF-H and NF-M subunits continue to be 
modified (58, 60, 63, 66) as they advance along axons em- 
phasizes that, even within the axon itself, the cytoskeleton is 
regionally specialized (6, 58).  Functional as well as struc- 
tural microdifferentiation of the axonal cytoskeleton is sup- 
ported by observations that neurofilament subunits in central 
axons compose neurofilaments of two types (62).  Neurofila- 
ments in the process of  translocation within the slowest phase 
of axoplasmic transport contribute to a lattice of neurofila- 
ments that is part of the stationary cytoskeletal network along 
axons (59, 62).  Stationary neurofilaments represent the pre- 
dominant pool of neurofilaments in mature retinal ganglion 
cell neurons, and this network is particularly prominent in 
distal axonal regions (59,  62). 
The existence of a stationary neurofilamentous cytoskele- 
ton as well as moving neurofilaments implies that the inter- 
actions  of these  cytoskeletal elements during  axoplasmic 
1. Abbreviations used in this paper: NF-H, high molecular mass (200-kD) 
neurofilament protein; NF-M, middle molecular mass neurofilament pro- 
tein; NF-L,  low molecular mass neurofilament protein. 
transport must be highly dynamic and tightly regulated.  Post- 
translational modifications of neurofilament proteins could 
coordinate these interactions by altering the affinity of neuro- 
filaments for other cytoskeletal structures (28, 47,  53,  55, 
74). Modifications of the high molecular mass neurofilament 
subunit may be particularly important for this process since 
NF-H subunits are believed to form cross-bridges that inter- 
connect neurofilaments and possibly link these elements to 
other cytoskeletal components and membrane-bound organ- 
elles (25, 75, 88).  Phosphate groups, for example, are added 
primarily to the hypervariable carboxy-terminal end of NF-H 
which protrudes from the neurofilament core and presum- 
ably interacts with other cytoskeletal proteins (8,  16, 32). 
To  further examine the cellular roles of NF-H and the 
significance of NF-H phosphorylation in regulating neuro- 
filament organization and function, we used a combination 
of biochemical,  cell  biological,  and  immunological  ap- 
proaches to identify major forms of NF-H in retinal ganglion 
cells and to characterize certain properties of these variants. 
Earlier studies showed that NF-H migrates on two-dimen- 
sional gels as a diffuse, sometimes discontinuous spot sug- 
gesting the presence of multiple microheterogeneous forms 
(7,  12, 20).  Recently, monoclonal antibodies were used to 
identify several differentially phosphorylated states of NF-H 
by immunoblot and immunocytochemical analysis (20, 42). 
In the present investigation, we used a range of criteria to 
identify different forms of NF-H in a single class of central 
neurons. In view of the complex dynamics of cytoskeletal 
elements during axoplasmic transport and maintenance of 
the axonal cytoskeleton, we focused on the microheteroge- 
neity of NF-H specifically within axons. The results of this 
study establish the existence of multiple forms of NF-H, the 
probable mechanism for their generation, and possible func- 
tional correlates of this structural microheterogeneity. 
Materials and Methods 
Animals and Tissue Preparation 
10-14-wk-old male or female mice of the C57BL/6J inbred strain were used 
in all experimental studies. Mouse breeding and maintenance and tissue dis- 
sections have been previously described (56, 63). The primary optic path- 
way,  termed optic axons, consisted of (a) the optic nerve severed at the 
scleral surface of the eye, (b) the optic chiasm, and (c) part of the optic tract 
extending to, but not including, terminals in the lateral geniculate nucleus. 
The entire dissected segment was 10 mm long. In some studies, optic path- 
ways were cut into consecutive 1.l-mm segments. Proteins soluble in  1% 
Triton X-100 solutions and Triton-insoluble cytoskeletal proteins were pre- 
pared from optic pathways by the method of Chiu and Norton (9) modified 
to include a  100,000 g final centrifugation instead of the usual 30,000 g cen- 
trifugation. 
Tissue Preparation and One-dimensional SDS-PAGE 
One-dimensional SDS-PAGE was performed by the procedure of Laemmli 
(36) using 320-mm slab gels containing 5-15 or 3-7 % polyacrylamide gra- 
dients.  Samples for electrophoresis were  prepared  under conditions de- 
signed to minimize proteolysis and protein loss. Samples were stored at 
-70°C  in the presence of 50 I.tg/mg leupeptin, 0.5 mM PMSE  and 2.5 
mg/ml aprotinin. To analyze unfractionated optic pathways in a single gel 
lane, a 2-3-rag wet weight of tissue (one optic pathway) was thawed in 150 
I.tl of ice-cold Laemmli buffer (62.5 mM Tris HC1, pH 6.8,  10% glycerol, 
and 0.002%  bromphenol blue) within a  small glass homogenizer. After 
homogenization, the samples were incubated on ice for 10 min with 2  t.tg 
each of RNase and DNase. A volume of 10% SDS (40 p,l) and 2-mercapto- 
ethanol (7 I11) was then added and the samples were boiled for  10 min, 
cooled, and loaded on gels. In some cases proteins in polyacrylamide slices 
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slices were first equilibrated to pH 6.8  in several changes of a  Tris-HCl 
buffer (62.5  mM,  pH 6.8)  containing 0.1%  SDS.  The  slices were then 
homogenized and prepared as described above for tissue homogenates, but 
the RNase and DNase incubation step was omitted. Proteins on gels were 
stained with 0.1% Coomassie Brilliant Blue (Schwarz-Mann, Cambridge, 
MA) and destained as previously described (7). 
Radiolabeling of Proteins in Retinal Ganglion Cells 
In Vivo 
Mice were injected intravitreally with 15-25 ~tCi of [2,3-3H]L proline (sp 
act, 30-50 Ci/mmol), 75  ttCi of [35S]methionine  (sp act, 400 Ci/mmol), 
or 30 IxCi of [32p]orthophosphate (sp act,  1,000 Ci/mmol) (New England 
Nuclear, Cambridge, MA) and were killed at 1-60 d after injection as previ- 
ously described (56, 63). After SDS-PAGE, radiolabeled proteins were de- 
tected by fluorography (38) or autoradiography. 
Radiolabeling of Glial Cell Proteins of the 
Optic Pathway In Situ 
Intact,  unlabeled optic pathways,  freshly dissected from mice, were in- 
cubaled for 60 min at 37°C in 0.5 ml of a Hepes medium (25 mM Hepes, 
5 mM KCI, 110 mM NaCI, 50 mM glucose, pH 7.4) containing 75 laCi of 
[35S]methionine  (sp act, 400 Ci/mmol). The medium was then replaced by 
1.0 ml of the same medium without radioisotopic amino acid but containing 
protein synthesis inhibitors (0.5 mM cycloheximide [Sigma Chemical Co., 
St. Louis, MO] and 0.3 mg/ml chloramphenicol [Sigma Chemical Co.]). 
Incubation in this medium was continued at 37°C for an additional 5 min. 
This was repeated once to remove unincorporated radioactivity, and the tis- 
sue was then frozen at  -70°C until analyzed (57). 
Radioiodination of  Proteins in Polyacrylamide 
Gel Slices 
Protein bands to be radiolabeled were excised from Coomassie Blue-stained 
PAGE gels and washed extensively with 10%  methanol over 3 d. The gel 
slices were lyophilized and then radiolabeled by the chloramine T procedure 
(15). 
Two-dimensional a-Chymotryptic 
Peptide Map Analysis 
Washed gel slices containing iodinated proteins were lyophilized and then 
incubated for 20 h at 37°C with 1.0 ml of 0.05 M NI-hHCO3, pH 8.0, con- 
taining 10 I.tg of ¢t-chymotrypsin. The digests were lyophilized, redissolved 
in  10-20 ml of Buffer I  (acetic acid/formic acid/H20,  15:5:80),  spotted 
onto cellulose-coated TLC plates, and subjected to electrophoresis in Buffer 
I at 1 kV for 30 min and then chromatographed in butanol/pyridine/acetic 
acid/H20  (32.5:25:5:20)  as described previously (15).  The  radioactive 
peptides were visualized by autoradiography. 
Alkaline Phosphatase Digestion of 
Cytoskeletal Proteins 
Cytoskeletal protein fractions were incubated at 37°C with Escherichia coli 
alkaline phosphatase (48 U/mg protein; Sigma Chemical Co., St.  Louis, 
MO) in 0.05 M Tris containing 100 mM NaCI, 0.5 mM PMSE 100 ttg/ml 
leupeptin, and 0.1% aprotinin. After a 5-h incubation, the cytoskeletal pro- 
teins were pelleted by centrifugation and prepared for SDS-PAGE as previ- 
ously described. 
Immunostaining with Monoclonal and 
Polyclonal Antibodies 
Optic pathway proteins on gels after SDS-PAGE were transformed onto 
nitrocellulose using 0.45-1am  nitrocellulose membranes (Millipore Con- 
tinental Water Systems, Bedford, MA). After transfer, unbound sites on the 
nitrocellulose were blocked for 1 h in 10% normal goat serum (Rockland, 
Inc., Gilbertsville, PA) in 50 mM Tris-HCl, pH 7.4, containing 0.9% NaCI 
and 0.1%  aprotinin. Blocked membranes were stained by an indirect im- 
munoperoxidase method  using  Y,3'-diaminobenzidine (Sigma  Chemical 
Co.) as the peroxidase substrate (5).  In some experiments, immunoblot 
analyses were carried out using 125I-labeled rabbit anti-mouse IgG (New 
England Nuclear, Boston, MA) as the secondary antibody in the indirect 
immunochemical procedure. In this case, immunoreactive proteins on nitro- 
cellulose papers were visualized by autoradiography. Antibodies used in this 
study included a polyclonal antiserum against phosphorylated epitopes on 
NF-H (obtained from Dr. R. Majocha) (7, 76), a monoclonal antibody (R3) 
against  phosphorylated epitopes on  NF-H  (14)  (obtained  from  Dr.  U. 
Drager), and monoclonal antibodies against phosphorylated and unphos- 
phorylated epitopes on NF-H (80),  SMI  31  and 32,  respectively (Stern- 
berger-Meyer Immunocytochemicals, Inc., Jarrettsville, MD). 
Quantitation of Unlabeled and Radiolabeled Proteins 
by Densitometry 
The relative content of Coomassie-stained proteins on SDS gels was quanti- 
tated by densitometry. Enlarged photographs of the stained gels were printed 
on Mylar transparent sheets and scanned using an Ultroscan laser densitom- 
eter (LKB Instruments, Inc., Gaithersburg, MD). Densities of regions on 
the gel corresponding to individual NF-H variants were quantitated by in- 
tegrating the area under the scanned region using a  computer digitizing 
board interfaced with a Bioquant software program (R &  M  Biometrics, 
Inc., Nashville, TN). Corrections for background were made by subtracting 
the density of an equivalent region of gel containing no protein bands. For 
a given experiment, all scans were performed at the same settings to enable 
direct comparisons of relative protein content.  All determinations were 
made at staining intensities that, in previous experiments, were observed to 
be in a range in which optical density was directly proportional to protein 
content. Radiolabeled proteins were similarly quantitated by densitometric 
analysis of autoradiograms or fluorograrns of appropriate exposures. A 
background value was subtracted which was equivalent to the density of a 
region of the gel lane that contained no radioactive protein bands. In some 
experiments (e.g., Fig.  11), scans of all samples were normalized to one 
same total  density (area under the curve).  Scans from replicate samples 
were then averaged together after calculating the density at consecutive 
points along each normalized scan. 
Results 
Heterogeneity of  2OO-kD Proteins in Axons of  Retinal 
Ganglion Cells 
Mouse optic axons contain proteins with apparent molecular 
masses of 195-210,  140-145,  and 70 kD, which have been 
identified by biochemical and physiological criteria (7, 63, 
65) as NF-H, NF-M, and NF-L, respectively. Although un- 
usual charge properties and extensive phosphorylation of the 
NF-M and NF-H subunits cause anomalous electrophoretic 
migration patterns that lead to overestimates of true molecu- 
lar size (17, 31, 34), molecular mass determinations by SDS- 
PAGE will be used to denote individual protein forms in 
these studies. 
On SDS  gels containing a  5-15%  acrylamide gradient, 
proteins in the 195-210-kD size range, referred to hereafter 
as the 200-kD proteins, appeared as a diffuse single band or 
doublet (Fig.  1,  lane b).  This region,  however,  could be 
resolved on 3-7%  acrylamide gradient gels into four Coo- 
massie Blue-stained bands displaying apparent molecular 
masses of 210, 205, 200, and 197 kD (Fig. 1, lane a). Since 
the patterns revealed by Coomassie Blue staining reflect the 
protein pools in optic glial cells as well as optic axons, we 
labeled proteins in optic axons selectively by injecting mice 
intravitreally with [35S]methionine and analyzed them after 
4 d (Fig. 1, lanes c and d). Four radiolabeled proteins (Fig. 
1,  lane d;  Fig.  2,  lanes c  and e)  were resolved that cor- 
responded in electrophoretic migration to the four 200-kD 
proteins visualized by Coomassie Blue staining. For reasons 
discussed later, the level of radioactivity associated with the 
210- and 197-kD proteins depended on the postinjection in- 
Lewis and Nixon Neurofilament  Protein  Variants in Axons  2691 Figure 1.  SDS-PAGE analysis of Coomassie Blue-stained  optic 
nerve proteins (lanes a and b) and radiolabeled polypeptides in op- 
tic axons of mice 3 d after intravitreal injection of [35S]methionine 
(lanes c and d). The region of the gels containing the 200-kD pro- 
teins is depicted. Top and bottom arrrows adjacent to lane b indicate 
the position of fodrin (235 kD) and NF-M (145 kD), respectively. 
The total protein content of optic axons, stained with Coomassie 
Brilliant Blue, is shown on gels containing polyacrylamide gra- 
dients of 3-7% (lane a) or 5-15% (lane b). 35S-labeled  proteins in 
optic axons, revealed by fluorography,  are shown on gels containing 
polyacrylamide gradients of 5-15% (lane c) or 3-7% (lane d). 
terval, but each of the four radiolabeled proteins was easily 
distinguished under certain conditions (Figs. 2,  5, and 6). 
Since assembled neurofilaments are considered to be high- 
ly insoluble polymers (52), we screened for putative forms 
of the NF-H subunit by determining the solubilities of the 
four 200-kD  proteins  in  Triton X-100  solutions.  Proteins 
from optic nerves of mice injected intravitreally with [35S]- 
methionine were partitioned into Triton-soluble and -insol- 
uble fractions and analyzed by SDS-PAGE. Coomassie Blue 
staining of these gels indicated that the Triton-insoluble frac- 
tion contained all  four 200-kD proteins (designated P210, 
P205, P200, P197) and that each was a major protein constit- 
uent of optic axons (Fig. 2, lane a; also Fig.  1, lane a). The 
Triton-soluble fraction, however, contained only a  197-kD 
protein (S197) in appreciable amounts (Fig. 2,  lane b). 
The composition of radiolabeled 200-kD proteins in these 
fractions  resembled  the  pattern  on  stained  gels  although 
some differences were noted.  P210,  the most prominently 
stained 200-kD protein, was weakly radiolabeled at 2 d after 
injection (Fig. 2, lane d) but discerned clearly after longer 
postinjection intervals (Fig. 2, lane e; also see below). The 
Triton-soluble  fraction  contained  prominent  radiolabeled 
Figure 2. SDS-PAGE  analysis of Triton-insoluble and Triton-solu- 
ble 200-kD proteins from unlabeled optic axons (lanes a and b) or 
optic axons obtained from mice 2 or 5 d after intravitreal injection 
of [35S]methionine  (lanes c-f, see below). Only the 200-kD region 
of the gels (3-7% polyacrylamide gradient) is depicted. Total pro- 
tein content from Triton-insoluble fractions (122 Ixg protein loaded) 
(lane a) and Triton-soluble fractions (182 ~tg protein loaded) (lane 
b) of optic axons was revealed by staining with Coomassie Brilliant 
Blue. Radiolabeled proteins in optic axons at 2 d after injection 
(lane c, soluble; lane d, insoluble) or at 5 d after injection (lane e, 
insoluble; lane  f, soluble) on adjacent lanes of the same gel were 
detected by fluorography.  Labeled soluble fractions contained 91 lag 
of protein and insoluble fractions contained 61  tJ-g of protein. 
200-kD  ($200)  and  197-kD  (S197)  polypeptides  (Fig.  2, 
lanes c and f) which were barely detectable by Coomassie 
Blue staining (Fig. 2, lane b). These results confirmed that 
retinal ganglion cells synthesize four Triton-insoluble and 
two Triton-soluble 200-kD proteins. Classification accord- 
ing  to  solubility  properties  proved  to  be  an  important 
criterion for identifying neurofilament proteins since the fol- 
lowing data show that only the insoluble 200-kD proteins in 
optic axons exhibited properties expected of neurofilament 
subunits. 
Structural Relatedness of  2OO-kD Proteins 
To examine the structural homology among 200-kD proteins, 
the Triton-soluble and -insoluble forms of these polypeptides 
were excised from gels, iodinated with L2sI, and subjected to 
two-dimensional peptide map analysis after a-chymotrypsin 
digestion. Of the 34 peptides clearly discernible on the pep- 
tide map of P210, 33 were present in P205, 32 were shared 
by P200, and 30 were present in P197. The P205 and P200 
proteins shared two to five additional peptides not detectable 
on the map of P210. In contrast to the high degree of struc- 
tural  homology among  Triton-insoluble 200-kD  proteins, 
only 10 of the peptides common to each of  these polypeptides 
had possible counterparts on the maps of the Triton-soluble 
proteins (Fig. 4). An additional 22-40 peptides on maps of 
$200 and S197 were not shared by the insoluble 200-kD pro- 
teins. Considerable homology (70-80%) was observed, how- 
ever, between the two Triton-soluble proteins (Fig. 4). 
Differential Axoplasmic Transport of the 
200-kD Proteins 
Intravitreal injection of radiolabeled amino acids intensely 
labels the three neurofilament subunits, which then advance 
along optic axons in the slowest phase (Group V or SCa) of 
axoplasmic transport (0.3-0.7 mm/d) (3, 26, 62, 87, 89). To 
compare the  transport  characteristics  of 200-kD  proteins 
with these established patterns, we injected mice intravitre- 
ally with [3H]proline and, after 3 or 7 d, divided the optic 
pathway into consecutive 1.1-mm segments (Fig. 5).  These 
were then separated into Triton-soluble and -insoluble frac- 
tions, subjected to electrophoresis, and quantitated by laser 
densitometry after fluorography. Changes in the distribution 
of individual Triton-soluble and -insoluble proteins between 
3 and 7 d (Fig. 5) demonstrated the progressive advance of 
these proteins along optic axons by axoplasmic transport as 
previously established (62, 63,  65).  At 7 d after injection, 
the transport wave containing P210,  P205, P200, and P197, 
which advanced at 0.3-0.5 mm/d, was clearly separated from 
the transport wave  containing Triton-soluble 200-kD pro- 
teins, which advanced at a typical Group IV (SCb) rate (1-2 
mm/d) based upon comparisons with other typical Group IV 
proteins (62). A small proportion of P205 protein also moved 
at a Group IV rate. An autoradiogram (Fig. 5, inset) depict- 
ing  the  labeling  patterns  of Triton-insoluble and  -soluble 
200-kD proteins in the optic nerve and optic tract at 5 d after 
isotope injection distinguished the P205 variant moving in 
Group IV from the other Triton-insoluble 200-kD proteins 
moving in Group V (Fig. 5, lanes a vs. b) and illustrates the 
appearance of $200 and S197 in the optic tract by 5 d (Fig. 
5,  lane d)  as predicted from a  Group IV transport rate (1 
mm/day) (Fig.  5,  lanes c vs.  d). 
The Journal of Cell Biology,  Volume 107, 1988  2692 Figure 3. Two-dimensional peptide map analyses of Triton-insoluble 200-kD proteins from mouse optic axons. Each of the four Triton- 
insoluble individual 200-kD proteins was excised from SDS gels, iodinated with ~25I, and digested with ct-chymotrypsin (see Materials 
and Methods). Chymotryptic peptides, separated in the first dimension (left to right) by high voltage electrophoresis and in the second 
dimension (bottom to top) by TLC, were revealed by autoradiography. Homologous configurations of peptides derived from P210, P205, 
P200, and P197 (a-d, respectively) are indicated on each peptide map. 
Phosphorylation and Dephosphorylation 
of 2OO-kD Proteins 
The subunits of all classes of intermediate filaments appear 
to contain phosphate (83).  Intravitreal injection of [32P]or- 
thophosphate in mice has also been shown to label a limited 
group of axonal proteins, which includes the three neurofila- 
ment subunits (61, 65). Among the 200-kD proteins, only the 
Triton-insoluble group incorporated 32p (Fig. 6, cf. lanes a 
and b). In separate experiments, glial proteins were radiola- 
beled in situ by incubating excised but otherwise intact optic 
nerves in the presence of [32P]orthophosphate  under condi- 
tions that preserve the cellular integrity of the tissue (Fig. 6, 
lanes c and d). Although numerous proteins including a-fo- 
drin (Fig.  6,  lane c) and myelin basic protein (not shown) 
were intensely labeled, no 32p radioactivity was detected in 
the 197-210-kD region of gel lanes containing Triton-insol- 
uble proteins (Fig. 6, lane c). Two Triton-soluble proteins in 
this region of the gel incorporated low levels of radioactivity 
(Fig.  6,  lane d). 
To obtain evidence for the in vivo phosphorylation of each 
of the four 200-kD proteins, we took advantage of a previous 
Lewis and Nixon Neurofilament  Protein  Variants in Axons  2693 Figure 4. Two-dimensional  peptide map analysis of Triton-soluble  200-kD axonal proteins. The ~t-chymotryptic  peptide maps of  the Triton- 
soluble 200-kD proteins $200 (A) and S197 (B) were prepared from mouse optic axons as described in Fig. 3. Autoradiograms  show com- 
mon configurations of peptides. 
observation (Fig. 2) that P197 was more prominently radio- 
labeled at the earliest postinjection timepoint and P205 and 
P210 were most abundant at longer survival times (also see 
below). Autoradiograms of 200-kD proteins in optic axons 
from mice obtained 5  h  after injection of [32Plorthophos- 
phate  revealed 32p  radioactivity evenly distributed within 
the region of the SDS gel that included P197 and P200 (Fig. 
6, lane  f). By 5 d after injection, radiolabeled forms in optic 
nerve  (Fig.  6,  lane  g)  and  optic  tract  (Fig.  6,  lane  h) 
comigrated predominantly in the region of P205 and P210 
and included only small proportions of  P200 and little, if  any, 
P197. The conclusion that each of the Triton-insoluble 200- 
kD  proteins  incorporated  32p  in vivo,  suggested by these 
distribution patterns,  was  further  supported  by  immuno- 
chemical studies below. 
Certain structural features of neurofilament subunits, in- 
cluding phosphorylation state, may be distinguished by the 
differential reactivity of the subunit with antibodies directed 
against specific peptide sequences or epitopes containing or 
lacking phosphate (80).  Individual 200-kD proteins excised 
from 3-7 % polyacrylamide  SDS gels were placed in adjacent 
lanes of a second SDS gel and subjected to electrophoresis 
again. The proteins were electroblotted onto nitrocellulose 
and immunostained with NF-H monoclonal antibodies. The 
four Triton-insoluble  polypeptides were detected by immuno- 
staining the transferred proteins with a monoclonal antibody 
(SMI 32) that recognizes phosphatase-insensitive (presum- 
ably nonphosphorylated) epitopes on neurofilament proteins 
(Fig.  7 A) (80).  SMI 31  (Fig.  7 B) (80)  and R3 (data not 
shown) (14), two monoclonal antibodies that exclusively rec- 
ognize phosphorylated epitopes, also immunostained these 
proteins. In addition, EL, an antiserum which is also specific 
for phosphorylated epitopes (76) recognized all four forms 
(Fig. 7 C). The 197-kD variant, however, reacted less strongly 
compared to the other proteins with SM131 but not with SMI 
32  (Fig. 7 B). This differential staining pattern was repro- 
ducibly seen in multiple analyses. In contrast to these results, 
the Triton-soluble 200-kD polypeptides did not cross-react 
with these antibodies (Fig. 7, lanes e and f). 
The majority of phosphate groups on NF-H can be re- 
moved in vitro by alkaline phosphatase treatment (8, 31, 65). 
We used this strategy to examine whether the Triton-insolu- 
ble 200-kD proteins were all phosphorylated or included a 
population of unphosphorylated NF-H variants. Axonal cy- 
toskeletal proteins before and after incubation with E.  coli 
alkaline phosphatase for 5 h at 37°C were compared by Coo- 
massie  Blue  staining  and  immunobtot analysis using the 
SMI32 and SMI31 antibodies (Fig.  8).  Dephosphorylation 
was associated with the complete disappearance of the four 
Triton-insoluble 200-kD proteins from their typical migra- 
tion positions on gels (Fig. 8, lanes a and c) and appearance 
of a major immunoreactive protein at 160 kD (Fig. 8, lanes 
b and d), where newly synthesized unmodified NF-H sub- 
units comigrate (18, 61, 69). The phosphorylated and dephos- 
phorylated NF-H subunits displayed a high degree of struc- 
tural  homology when two-dimensional iodopeptide maps 
were analyzed after digestion with tt-chymotrypsin: more 
than 95 % of the major peptides were  shared in common 
(Fig. 9). 
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for Triton-soluble  and Triton-insoluble  200-kD proteins  from mice 
3 or 7 d after intravitreal  injection of [3H]proline. The optic nerves 
and proximal  optic tracts  of groups of 20 mice at each timepoint 
were divided  into nine consecutive 1.1-mm segments,  which were 
then  separated  into  Triton-soluble  and Triton-insoluble  fractions 
and subjected  to SDS-PAGE (3-7% polyacrylamide gradient).  Ra- 
dioactivity associated  with the four Triton-insoluble  200-kD pro- 
teins  (solid lines) P210 (o),  P205 (I), P200 (A), and  P197 (,), 
and two Triton-soluble  200-kD proteins  (dotted lines), $200 ([]) 
and S197 (<>), was determined on fluorograms  by laser densitome- 
try. The relative distribution  of  each radiolabeled  polypeptide along 
optic axons at 7 d after injection  is illustrated.  The optic chiasm be- 
gins after segment 5. The peaks of the transport wave for the labeled 
Triton-insoluble  proteins (solid arrow) and Triton-soluble  proteins 
(dotted arrow) at 3 d after injection  are indicated  to illustrate  the 
movement of the wave during this time interval.  (Inset) Autoradio- 
gram from a single SDS gel (3-7% polyacrylamide gradient)  con- 
raining radiolabeled  proteins in Triton-insoluble  (lanes a and b) and 
Triton-soluble  (lanes c and d) fractions  of optic nerve (lanes a and 
c) and optic tract (lanes b and d) 5 d after mice were injected  in- 
travitreally  with  [35S]methionine.  Protein  loads  on  gels  are  the 
same as those in Fig. 2. 
Figure 6. Autoradiograms of 200-kD proteins in optic axons of mice 
radiolabeled  by intravitreal  injection of [32P]orthophosphate (lanes 
a, b, and f-h) or [35S]methionine (lane e).  Proteins  in optic nerve 
glia were selectively  labeled  by [32p]orthophosphate (lanes  c and 
d)  as  described  in  Materials  and  Methods.  Triton-soluble  and 
-insoluble fractions of radiolabeled  proteins in neurons (lanes a and 
b, respectively) and glia (lanes d and c, respectively)  were analyzed 
by SDS-PAGE (3-7% polyacrylamide gradient)  followed by autora- 
diography. Fractions  from equivalent masses of labeled optic axons 
or optic glia are shown. Protein loads on gels are the same as those 
in Fig. 2. Lanes e-h depict autoradiograms  of SDS gels containing 
200-kD proteins  from optic nerve  3 d after [35S]methionine (lane 
e); optic nerve 5 h after  [32p]orthophosphate  (lane f); optic nerve 
5 d after [32p]orthophosphate (lane g); optic tract 5 d after [32P]or- 
thophosphate  (lane h). Lanes e, g, and h are taken from the same 
SDS gel. A second [35S]methionine-labeled optic nerve (not shown), 
subjected  to electrophoresis  in the lane adjacent  to lane f, enabled 
precise  alignment  of lanefwith other lanes in this figure. Varying 
exposure times were used for autoradiograms of each lane to facili- 
tate comparisons. 
axons: those undergoing continuous slow axoplasmic trans- 
port and those that are stationary and comprise the predomi- 
nant neurofilament network along optic axons (62).  To seek 
differences in the association of individual Triton-insoluble 
Non-Uniform Distribution of 2OO-kD Proteins along 
Optic Axons 
Neurofilaments  are  twice  as  numerous  at  distal  levels  of 
mouse optic axons than at proximal levels. To investigate the 
relationship of the individual  Triton-insoluble 200-kD pro- 
teins (NF-H variants) to steady-state pools of neurofilaments, 
we examined  the  axonal  distributions  of these  variants  by 
measuring the total content of each variant in proximal, mid- 
dle, and distal levels of the optic nerve and optic tract by laser 
densitometry  after  the  proteins  were  separated  by  SDS- 
PAGE and stained with Coomassie Blue.  The content of the 
210- and 205-kD polypeptides, like that of NF-M and NF-L 
subunits,  increased markedly from proximal to distal levels 
of optic axons (Fig.  10). The P200 variant, by contrast, dis- 
played a  relatively uniform distribution.  Finally,  P197 was 
the  most prominent variant  in proximal  segments  but was 
the  least  prominent  variant  at  distal  levels  of optic  axons 
(Fig.  10). 
Association of 2OO-kD Proteins with the Stationary 
Neurofilament Network along Axons 
Previous studies demonstrate that neurofilament proteins are 
associated with at least two types of neurofilaments in optic 
Figure 7. Immunoblot analysis of 200-kD proteins with anti-NF-H 
monoclonal  antibodies  directed  against  phosphatase-insensitive 
epitope(s) (SM132; A) or phosphatase-sensitive  epitope(s) (SM131; 
B), and a polyclonal antiserum directed against phosphatase-sensi- 
tive epitope(s)  on NF-H (7, 76) (EL; C). Triton-insoluble  proteins 
from optic axons were separated  by SDS-PAGE (3-7%  polyacryl- 
amide gradient).  Individual bands corresponding to the four Triton- 
insoluble proteins  P210 (lane a), P205 (lane b), P200 (lane c), and 
P197 (lane d), and two Triton-soluble  proteins,  $200 (lane e) and 
S197 (lane f), were separated by SDS-PAGE (3-7 % polyacrylamide 
gradient),  excised from the gel, subjected again to electrophoresis 
in adjacent lanes of a second gel, and then subjected to Western blot 
analysis.  An amount of each polypeptide derived  from an equiva- 
lent amount of fresh tissue (4 mg) was loaded into each lane. 
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of NF-H subunits before and 
after neurofilaments in Triton- 
insoluble  fractions  of  optic 
axons were dephosphorylated 
by incubation for 5 h in vitro 
with E. coli  alkaline phospha- 
tase. A combination ofSM131 
and  SMI  32  antibodies  was 
used in Western blot analysis 
to detect NF-H before (lane a) 
or after (lane b) dephosphory- 
lation. Equal amounts of pro- 
tein (120 gg) were applied to 
each  lane.  For  comparison, 
the same SDS gel, after elec- 
troblotting,  was  stained  with 
Coomassie  Blue  to  demon- 
strate  the  remaining  protein 
corresponding to NF-H before 
(lane c) and after (lane d) de- 
phosphorylation. 
200-kD  proteins  (NF-H  variants)  with  these  two  types  of 
neurofilaments, we compared the proportions of each radio- 
labeled variant as radiolabeled neurofilament proteins were 
initially  entering axons in the advancing wavefront of slow 
axoplasmic transport  and at stages during  and after the in- 
tegration  of transported  neurofilaments  into  the  stationary 
cytoskeleton (Fig.  11). Mice injected intravitreally with [ass]- 
methionine  were  analyzed  at timepoints  when  (a)  labeled 
neurofilaments were predominantly in a moving phase (3 d), 
(b) both moving and stationary neurofilaments were well ra- 
diolabeled  (15  d),  or  (c)  labeled  stationary  neurofilaments 
predominated  along  optic  axons  (60  d).  These  timepoints 
were based on the results of previous studies (62). The optic 
axon  segments,  dissected  from  mice  at  these  three  time- 
points,  were  fractionated  and  the  Triton-insoluble  fraction 
was analyzed by SDS-PAGE. Densitometric scans of the au- 
Figure 10. Axonai distribution 
of  the  four  NF-H  variants 
P210,  P205,  P200,  and  P197, 
at  distances  0-1.1,  2.2-3.3, 
and 5.5-6.6 mm from the eye 
as indicated  on the graph. Tri- 
ton-insoluble  fractions  were 
prepared  from each  of these 
sets of 1.1-mm segments of  the 
optic pathway pooled from 20 
mice.  After  SDS-PAGE  (3- 
7% polyacrylamide gradient), 
the regions of the Coomassie 
Blue-stained gel corresponding to each of the four NF-H variants 
were analyzed by laser densitometry and the total protein content, 
expressed in arbitrary units,  was plotted. 
toradiographs  from multiple gels demonstrated that,  at 3  d 
after injection, polypeptides migrating within the 195-205-kD 
region of the gel were the most intensely labeled NF-H vari- 
ants (Fig.  11). By 60 d  after injection,  labeling in the  195- 
197-kD region was markedly diminished; however, P210 was 
intensely labeled,  and P205  also displayed increased radio- 
activity.  At  the  15-d  postinjection  timepoint,  when  both 
moving and stationary neurofilaments were radiolabeled, the 
radioactivity  displayed  a  pattern  intermediate  between  the 
3- and  60-d  timepoints. 
Discussion 
Multiple Structural Variants of NF-H in Axons 
In this  study,  we have  identified  a  set of four  197-210-kD 
polypeptides  as variants of the  NF-H subunit  of neurofila- 
ments.  The property  of Triton  X-100  insolubility,  a  previ- 
ously  established  characteristic  of  axonal  neurofilaments 
(51), effectively distinguished  all neurofilament-related 200- 
Figure 9. Two-dimensional peptide map analysis of NF-H subunits before (A) and after (B) neurofilaments were dephosphorylated by incuba- 
tion for 5 h in vitro with E. coli alkaline phosphatase. Iodopeptide map analysis after ct-chymotrypsin digestion was performed as described 
in Fig.  3.  Homologous configurations of peptides are indicated. 
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Figure 11. Relative proportions of 
radiolabeled NF-H variants pres- 
ent in optic axons from mice in- 
jected intravitreally with pS]me- 
thionine and killed after 3 (o), 15 
(e), and 60 (<>) d. After Triton- 
insoluble proteins were separated 
by SDS-PAGE, the relative radio- 
activity of individual NF-H vari- 
ants  was determined on autora- 
diograms by laser densitometry. 
Since the absolute radioactivity 
of NF-H varied at the different 
postinjection timepoints, the dif- 
ferent scans were normalized to 
the same total radioactivity; i.e., 
area under  the  scan. Each data 
point represents the mean + SEM 
for three to four separate experi- 
ments. The approximate locations 
along the scan corresponding to 
each NF-H variant are provided 
at the top of the figure. 
kD proteins in optic axons from unrelated proteins with simi- 
lar  apparent  molecular  masses.  Each  of the  four Triton- 
insoluble 200-kD proteins was synthesized in neurons (Figs. 
1 and 2), advanced along axons predominantly or exclusively 
in the Group V (SCa) phase of axoplasmic transport (3, 89) 
(Fig.  5),  and incorporated phosphate groups in  vivo (30) 
(Fig. 6). In addition, each of the four proteins cross-reacted 
with antibodies to an epitope common to all classes of inter- 
mediate filament proteins (72) (data not shown) and with a 
set of monoclonal and polyclonal antibodies against NF-H 
(Fig. 7). Finally, the four polypeptides displayed more than 
90% homology by two-dimensional peptide map analysis af- 
ter ¢t-chymotryptic digestion (Fig. 3). The extremely close 
structural homology between these NF-H variants suggests 
that relatively small modifications that influence the charge 
or conformation of the protein accounted for apparent molec- 
ular mass differences on SDS gels. Although closely related, 
the individual NF-H variants could be clearly distinguished 
from each other by differences in their electrophoretic mo- 
bilities,  their  relative  specific  radioactivities  at  different 
times after pulse-labeling with pS]methionine in vivo, and 
their regional distribution along axons. 
Two Triton-soluble 200-kD proteins, by contrast, satisfied 
few if any conventional criteria for neurofilament protein 
identification. Although they displayed apparent molecular 
masses  roughly similar to those of certain NF-H variants, 
they were transported more rapidly than neurofilament pro- 
teins Group IV or SCb transport phase (Fig. 5), did not in- 
corporate phosphate in vivo (Fig.  6), and were not recog- 
nized by antibodies to NF-H (Fig. 7) or to the general class 
of intermediate filaments (72).  They displayed some struc- 
tural similarities to each other but only limited peptide ho- 
mology with the NF-H variants (Fig. 4). Despite some struc- 
tural  similarities  with  NF-H,  the  Triton-soluble  200-kD 
proteins do not represent nonphosphorylated forms of  NF-H, 
since unmodified NF-H subunits,  as well as enzymatically 
dephosphorylated NF-H subunits, display an apparent mo- 
lecular mass of 160 kD and retain more than 90 % of peptide 
homology with extensively modified, insoluble forms of NF- 
H (Fig. 9). The high degree of homology between iodopep- 
tide maps of phosphorylated and dephosphorylated forms of 
NF-H is not unexpected since many of the phosphate-rich 
chymotryptic peptides are unlabeled or weakly labeled by 
'25I (Sihag, R. K., and R. A. Nixon, unpublished observa- 
tions), suggesting, therefore, that they either lack iodination 
sites or that phosphorylation blocks iodination of potential 
sites on these peptides. It is also difficult to account for $200 
and S197 as soluble proteolytic derivatives of NF-H variants 
since they contained no label after [32p]orthophosphate ad- 
ministration. The heavily phosphorylated region of NF-H is 
at least 65 kD in size (16),  and its removal should result in 
large molecular mass  changes.  This conclusion is further 
supported by the observation that each of the Triton-soluble 
proteins displays many a-chymotrypsin peptides that are not 
shared by any of the NF-H variants (Fig. 4). 
One or both of the 200-kD soluble polypeptides may cor- 
respond to brain myosin (48), which migrated to an apparent 
molecular mass in the 197-200-kD range (Lewis, S. E., and 
R.  A.  Nixon, unpublished observations).  In addition,  we 
have observed that  several  [35S]methionine-labeled axonal 
polypeptides with similar apparent molecular masses coas- 
semble with microtubules, suggesting that one or both may 
be microtubule-associated proteins (Nixon,  R.  A.,  and I. 
Fischer,  unpublished  observations).  A  group of similarly 
sized microtubule-associated proteins has been observed in 
rat liver (35). 
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Phosphoproteins 
Previous studies suggest several possible mechanisms to ac- 
count for NF-H microheterogeneity,  which was initially noted 
in early two-dimensional gel analyses of axonal neurofila- 
ment proteins (5,  12). The existence in rabbits of two NF-H 
isoforms differing in apparent molecular mass by 10,000 D 
is attributed to genetic polymorphism (86,  87).  This phe- 
nomenon has not been observed in other species, including 
mice. Other examples of neurofilament protein microheter- 
ogeneity reflect modifications to the protein after it is synthe- 
sized. Limited proteolysis during axoplasmic transport, for 
example, generates major NF-M variants of lower apparent 
molecular mass that display a non-uniform distribution along 
optic axons (63, 67). These limited proteolytic modifications 
of NF-M within axons are distinct from the degradation of 
neurofilament polypeptides that reach nerve terminals (37, 
58).  In similar extensive studies of NF-H, we were unable 
to demonstrate interconversion of NF-H variants by limited 
proteolysis in  vivo or  in  vitro  (Lewis,  S.  E.,  and R.  A. 
Nixon, unpublished observations). 
Neurofilament protein microheterogeneity is also gener- 
ated by protein phosphorylation (4,  18, 20, 30, 41, 69,  80) 
and dephosphorylation (60). The immunocytochemical de- 
tection of phosphorylated neurofilaments predominantly in 
axons and relatively less phosphorylated or unmodified sub- 
units in neuronal perikarya (2, 41, 42, 80) has been corrobo- 
rated by biochemical studies showing that newly synthesized 
NF-H and NF-M are extensively phosphorylated as they en- 
ter axons (1, 4,  18, 61). These previous studies of various 
neuron types have identified two NF-H variants, a relatively 
unmodified (160-kD)  form predominating in perikarya and 
a phosphorylated (200-kD) form present in axons. The pos- 
sibility that neurons contain multiple phosphorylated NF-H 
variants as major constituents of the axonal neurofilament 
lattice, however, was suggested by observations that each of 
the individual triplet proteins continues to undergo unique 
sequences of phosphorylation and dephosphorylation events 
during axoplasmic transport (60,  65). 
Several lines of evidence indicate that microheterogeneity 
of NF-H  subunit structure in optic axons arises by phos- 
phorylation, and possibly dephosphorylation, during axonal 
transport. NF-H, the most highly phosphorylated subunit, 
contains between 25 and 50 phosphate groups per molecule 
(8, 29, 30).  Since phosphate addition slows the electropho- 
retic mobility of many proteins (55),  including NF-H (30, 
34),  varying phosphorylation states  can easily account for 
differences in apparent molecular masses of the NF-H vari- 
ants. When neurofilaments from mouse optic axons were en- 
zymatically dephosphorylated, the four NF-H variants dis- 
appeared, giving rise to a 160-kD polypeptide (Fig. 8). This 
extensively dephosphorylated form comigrates on SDS gels 
with newly synthesized (unmodified) NF-H subunits labeled 
in vivo (61). These observations suggest that the varying mo- 
lecular masses of the NF-H variants do not reflect size differ- 
ences but, rather, changes in the electrophoretic mobility of 
the polypeptide induced by phosphate addition (34). Although 
it is conceivable that the varying electrophoretic mobilities 
of NF-H isoforms could reflect different conformational states 
of identically phosphorylated molecules, other data suggest 
that NF-H variants differ in net phosphorylation state. Previ- 
ous studies indicate that phosphorylated NF-H subunits with 
the slowest electrophoretic mobility on SDS gels display a 
more acidic charge by IEF than subunits with a faster mobil- 
ity (20, 82).  Furthermore, the conversion of NF-H variants 
from lower to higher apparent molecular masses during ax- 
onal transport in optic axons (Figs.  2 and 6) is associated 
with a shift in isoelectric point of the NF-H subunit pool to- 
ward more acidic pH values, which is consistent with phos- 
phate addition (65). 
Available  evidence  suggests  that  phosphorylation  may 
serve as a  mechanism for coordinating the interactions of 
neurofilaments with other cytoskeletal elements during axo- 
plasmic  transport  (65,  68).  Neurofilament protein  phos- 
phorylation is a dynamic process involving multiple protein 
kinases (32, 33, 43, 77) and phosphatases (60).  Not only do 
neurofilaments continue to be phosphorylated as they are 
transported along axons (65) but initially incorporated phos- 
phate groups are also turned over with a specific timing and 
dependence on location within the axon (60).  The rate of 
phosphate turnover is different for each of the neurofilament 
triplet proteins (60), and phosphates are removed preferen- 
tially from specific sites  on at least the NF-L and NF-M 
subunits. Kinase and phosphatase systems involved in neu- 
rofilament phosphorylation, therefore, have the diversity and 
apparent specificity required of a mechanism for regulating 
complex protein-protein interactions.  In addition to these 
observations,  it is known that phosphates are primarily added 
to the carboxy-terminal tailpiece of NF-H which protrudes 
from the neurofilament core and presumably interacts with 
other cytoskeletal proteins (8, 16, 32).  Electron microscopic 
studies (25, 75, 88) support the function of  the peripheral do- 
main of NF-H, in particular, as a cross-link between neuro- 
filaments and microtubules. Other cytoskeletal proteins that 
may link intermediate filaments with microtubules or with 
the plasma membrane have also been shown to be phospho- 
proteins (55). For some of these proteins, phosphate addition 
to or removal from specific sites on the polypeptide markedly 
changes its binding affinities (23, 28, 47, 53, 73,  74). 
Functional Implications of NF-H Microheterogeneity 
The presence of multiple NF-H variants within axons of a 
single class of  central neurons raises the possibility that these 
isoforms serve different functions. The suspected role of the 
NF-H subunits in forming cross-links between cytoskeletal 
elements (24, 25, 75, 88) is an additional reason to view the 
structural diversity of NF-H in functional terms. NF-H sub- 
units form 4-6-nm-diam and 20-60-nm-long cross-bridges 
that link neurofilaments to other neurofilaments and possibly 
to microtubules and membrane-bound organelles (24).  In 
addition, cross-bridges of different dimensions have been 
observed between neurofilaments and other organelles (24) 
although the participation of NF-H has not been frmly estab- 
lished. In developing neurons, the late appearance of phos- 
phorylated forms of NF-H, after that of NF-L and NF-M (13, 
71, 87), coincides with the transition from a state in which 
few interneurofilamentous  cross-bridges  exist to one in which 
most  axonal  neurofilaments are  extensively cross-linked. 
This major reorganizational event during development may 
reflect changes in the functional state of the neurofilamentous 
cytoskeleton. 
Mature retinal ganglion cell neurons contain two distinct 
axonal pools  of neurofilaments which may have  different 
functions (62).  One pool, which is conveyed along axons in 
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displays a half-life of 17-20  d. These axonally transported 
neurofilaments contribute to a second, larger population that 
is stationary and forms a non-uniform neurofilament  network 
along axons. This network, together with other stationary 
cytoskeletal elements (62), comprises a complex that turns 
over with a relatively long half-life ('~55 d) (62). We have 
proposed that moving neurofilaments, unassociated or weak- 
ly associated with other cytoskeletal proteins, represent a rel- 
atively rapid mechanism for modifying axonal geometry to 
effect, for example, moderate changes in axonal caliber (27) 
or to repair local injury (58). While providing structural sup- 
port, moving neurofilaments could also allow the degree of 
plasticity required by, for example, a growing axon during 
development. By contrast, the stationary neurofilament lat- 
tice in mature neurons is well suited as a framework to stabi- 
lize a given axonal shape, direction, or spatial orientation, 
and to organize and anchor constituents within the axoplasm 
(61, 62). 
Our results provide evidence for a differential association 
of NF-H variants with the moving and stationary neurofila- 
ments networks in optic axons. The 210- and 205-kD variants 
were observed to be major NF-H constituents of the station- 
ary neurofilamentous cytoskeleton. These NF-H variants ap- 
pear to arise from one or more of the lower molecular mass 
variants during axoplasmic transport since a shift from pre- 
dominantly 197-205-kD forms at 3 d after pulse-radiolabel- 
ing  (e.g.,  Figs.  2  and  11)  to  predominantly 205-210-kD 
forms at 15 d (Fig. 11) occurs without a significant decrease 
in total NF-H radioactivity (62).  This conversion accords 
with previous observations that the phosphorylation state of 
NF-H  increases  during  this  time  interval  as  axoplasmic 
transport proceeds (65).  The 197-kD NF-H variant, by con- 
trast, appears to be predominantly associated with the popu- 
lation of moving neurofilaments. This polypeptide was the 
principal NF-H form entering optic axons within 3 to 48 h 
after pulse-labeling in vivo (Figs. 6 and 11), and transport 
kinetics indicate that most neurofilaments at very proximal 
levels of optic axons are moving (62). Estimates of the total 
content of the four NF-H variants along axons (Fig.  10), in 
addition to showing that each is a major axonal protein, fur- 
ther support the distinction between neurofilaments predom- 
inantly composed of 197-kD NF-H subunits and those con- 
taining the 205- and 210-kD  NF-H forms. The proximal to 
distal increase in P210 and P205 content along optic axons 
parallels the non-uniform deposition of neurofilaments con- 
taining radiolabeled P210 and P205 variants into the station- 
ary cytoskeleton (62). If  P197 were associated primarily with 
moving neurofilaments, its steady-state level along axons can 
only be expected to diminish proximally to distally, as we ob- 
served, when moving neurofilaments containing P197 vari- 
ants become stationary neurofilaments containing P205 and 
P210  variants. Finally, P200 was a  component of radiola- 
beled neurofilaments entering optic axons and those remain- 
ing in optic axons at 60 d after [35S]methionine injection. 
The smaller proximal to distal differences observed in the 
content of this variant along axons are, therefore, consistent 
with its apparent  association with moving and  stationary 
neurofilaments. 
Changes in the phosphorylation state of NF-H, reflected 
by the relative proportions of each NF-H variant, could, jn 
fact, be viewed as a mechanism to regulate partitioning of 
neurofilaments between the moving and stationary neurofila- 
ment network. An analogy may be drawn to previously ob- 
served effects of phosphorylation on myosin structure (11). 
In the unphosphorylated state, myosin head domains are held 
down in  the  myosin filament backbone by head-head or 
head-backbone interactions. Phosphorylation inhibits these 
interactions causing the head domains to extend outward, 
which thereby facilitates cross-bridge formation with actin. 
By analogy, relatively dephosphorylated carboxyl-terminal 
domains of NF-H (and possibly NF-M) would be expected 
to have increased affinity for the filament core and to effect, 
therefore, a conformation of the neurofilament that is steri- 
cally favorable for its entry into the axon and its initial trans- 
port.  Indeed,  neurofilaments in  some  neurons  appear  to 
move at faster rates as they initially enter axons than when 
they reach more distal levels of the axon. Progressive phos- 
phorylation of the carboxy-terminal domains of NF-M and 
NF-H would reduce interaction with the filament core, and 
the resulting radial extension of these domains would be ex- 
pected to retard neurofilament movement and favor inter- 
actions with axonal elements, including constituents of the 
stationary cytoskeleton. Different conformations of the car- 
boxy-terminal domains, represented by the different NF-H 
variants, might, therefore, define certain properties of the 
cross-bridges such as the spacing, reversibility, and speci- 
ficity for moving or stationary elements. 
Functional distinctions among different NF-H  isoforms 
are further suggested by immunoblot analyses with a mono- 
clonal antibody that recognizes a phosphatase-sensitive epi- 
tope on NF-H (2,  13).  This antibody has been previously 
shown to immunostain axons only late in neuron develop- 
ment, considerably after the NF-H polypeptide appears and 
undergoes a certain degree of posttranslational modification 
by phosphate (2,  13). We have observed that this antibody 
recognizes the 210- and 205-kD NF-H variants and to a much 
lesser extent recognizes the 200 kD NF-H variant, but does 
not immunostain the  197-kD  form (Nixon,  R.  A.,  S.  E. 
Lewis, and D.  Dahl, unpublished observations).  Thus, the 
same NF-H variants that are distinguished by their differen- 
tial associations with moving and stationary neurofilament 
networks appear also to be distinguished by the timing of 
their appearance during development. 
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